DUXA
gene geneOn this page
Summary
DUXA (double homeobox A, HGNC:32179) is a protein-coding gene on chromosome 19q13.43, encoding Double homeobox protein A (A6NLW8). Transcription factor that acts as a repressor.
Homeobox genes encode DNA-binding proteins, many of which are thought to be involved in early embryonic development. Homeobox genes encode a DNA-binding domain of 60 to 63 amino acids referred to as the homeodomain. This gene is a member of the DUXA homeobox gene family. Evidence of mRNA expression has not yet been found for this gene. Multiple, related processed pseudogenes have been found which are thought to reflect expression of this gene in the germ line or embryonic cells.
Source: NCBI Gene 503835 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 32 total
- MANE Select transcript:
NM_001012729
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:32179 |
| Approved symbol | DUXA |
| Name | double homeobox A |
| Location | 19q13.43 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000258873 |
| Ensembl biotype | protein_coding |
| OMIM | 611168 |
| Entrez | 503835 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000554048
RefSeq mRNA: 1 — MANE Select: NM_001012729
NM_001012729
CCDS: CCDS33126
Canonical transcript exons
ENST00000554048 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001469905 | 57155267 | 57155372 |
| ENSE00001469909 | 57158328 | 57158473 |
| ENSE00001469913 | 57159167 | 57159278 |
| ENSE00001469917 | 57160643 | 57160797 |
| ENSE00002445070 | 57154021 | 57154482 |
| ENSE00002471883 | 57167419 | 57167485 |
Expression profiles
Bgee: expression breadth broad, 20 present calls, max score 47.28.
Top tissues by expression
102 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| calcaneal tendon | UBERON:0003701 | 47.28 | gold quality |
| left coronary artery | UBERON:0001626 | 42.52 | gold quality |
| sural nerve | UBERON:0015488 | 41.67 | silver quality |
| descending thoracic aorta | UBERON:0002345 | 41.32 | gold quality |
| cortical plate | UBERON:0005343 | 40.52 | silver quality |
| thoracic aorta | UBERON:0001515 | 39.43 | gold quality |
| apex of heart | UBERON:0002098 | 39.20 | silver quality |
| ascending aorta | UBERON:0001496 | 38.89 | gold quality |
| right coronary artery | UBERON:0001625 | 37.76 | silver quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| corpus callosum | UBERON:0002336 | 37.09 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| tibial artery | UBERON:0007610 | 36.40 | gold quality |
| popliteal artery | UBERON:0002250 | 36.39 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 34.99 | gold quality |
| mucosa of stomach | UBERON:0001199 | 33.78 | gold quality |
| muscle tissue | UBERON:0002385 | 33.34 | gold quality |
| bone marrow | UBERON:0002371 | 32.98 | gold quality |
| blood | UBERON:0000178 | 32.68 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| gall bladder | UBERON:0002110 | 31.43 | silver quality |
| liver | UBERON:0002107 | 31.40 | gold quality |
| monocyte | CL:0000576 | 31.39 | silver quality |
| leukocyte | CL:0000738 | 31.04 | silver quality |
| subcutaneous adipose tissue | UBERON:0002190 | 30.16 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.77 | gold quality |
| placenta | UBERON:0001987 | 29.58 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.29 |
Regulation
Is transcription factor: yes
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA0884.1 | DUXA | Paired-related HD factors |
| MA0884.2 | DUXA | Paired-related HD factors |
JASPAR matrix evidence (PMIDs): PMID:24278031
miRNA regulators (miRDB)
109 targeting DUXA, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6867-5P | 100.00 | 82.21 | 3464 |
| HSA-MIR-3064-3P | 100.00 | 70.09 | 1254 |
| HSA-MIR-4776-3P | 100.00 | 68.73 | 1340 |
| HSA-MIR-150-5P | 99.99 | 66.69 | 1976 |
| HSA-MIR-5696 | 99.98 | 72.36 | 4487 |
| HSA-MIR-4482-3P | 99.98 | 72.50 | 3147 |
| HSA-MIR-6778-3P | 99.96 | 67.29 | 2693 |
| HSA-LET-7C-3P | 99.95 | 73.42 | 2862 |
| HSA-MIR-559 | 99.95 | 72.28 | 3609 |
| HSA-MIR-548AB | 99.95 | 71.31 | 3488 |
| HSA-MIR-548I | 99.94 | 71.25 | 3481 |
| HSA-MIR-548A-5P | 99.94 | 71.27 | 3482 |
| HSA-MIR-548AD-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548AE-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548AK | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AM-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AP-5P | 99.94 | 71.14 | 3489 |
| HSA-MIR-548AR-5P | 99.94 | 71.28 | 3515 |
| HSA-MIR-548AS-5P | 99.94 | 71.22 | 3482 |
| HSA-MIR-548AU-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AY-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548B-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548BB-5P | 99.94 | 71.27 | 3509 |
| HSA-MIR-548C-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548D-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548H-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548J-5P | 99.94 | 71.14 | 3489 |
| HSA-MIR-548O-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548W | 99.94 | 71.24 | 3488 |
| HSA-MIR-548Y | 99.94 | 71.28 | 3514 |
Cross-species orthologs
0 orthologs
Paralogs (50): ARX (ENSG00000004848), PAX6 (ENSG00000007372), PAX7 (ENSG00000009709), ALX4 (ENSG00000052850), GSC2 (ENSG00000063515), PITX1 (ENSG00000069011), PAX2 (ENSG00000075891), RHOXF1 (ENSG00000101883), CRX (ENSG00000105392), EVX1 (ENSG00000106038), PAX4 (ENSG00000106331), NOBOX (ENSG00000106410), PITX3 (ENSG00000107859), PHOX2B (ENSG00000109132), OTX1 (ENSG00000115507), PRRX1 (ENSG00000116132), VSX2 (ENSG00000119614), ESX1 (ENSG00000123576), PAX8 (ENSG00000125618), PAX1 (ENSG00000125813), RHOXF2 (ENSG00000131721), GSC (ENSG00000133937), RAX (ENSG00000134438), PAX3 (ENSG00000135903), ALX3 (ENSG00000156150), HESX1 (ENSG00000163666), PITX2 (ENSG00000164093), UNCX (ENSG00000164853), PHOX2A (ENSG00000165462), OTX2 (ENSG00000165588), DRGX (ENSG00000165606), PRRX2 (ENSG00000167157), SHOX2 (ENSG00000168779), OTP (ENSG00000171540), RAX2 (ENSG00000173976), EVX2 (ENSG00000174279), PROP1 (ENSG00000175325), ISX (ENSG00000175329), ALX1 (ENSG00000180318), MIXL1 (ENSG00000185155)
Protein
Protein identifiers
Double homeobox protein A — A6NLW8 (reviewed: A6NLW8)
All UniProt accessions (1): A6NLW8
UniProt curated annotations — full annotation on UniProt →
Function. Transcription factor that acts as a repressor.
Subcellular location. Nucleus.
Tissue specificity. Expressed in embryonic stem cells.
Similarity. Belongs to the paired homeobox family.
RefSeq proteins (1): NP_001012747* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000047 | HTH_motif | Conserved_site |
| IPR001356 | HD | Domain |
| IPR009057 | Homeodomain-like_sf | Homologous_superfamily |
| IPR051306 | Homeobox_regulator | Family |
Pfam: PF00046
UniProt features (7 total): DNA-binding region 2, region of interest 2, compositionally biased region 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A6NLW8-F1 | 76.04 | 0.52 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-9819196 | Zygotic genome activation (ZGA) |
MSigDB gene sets: 25 (showing top):
GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, MIR513A_3P_MIR513C_3P, MIR3606_3P, MIR548L, MIR4291, MIR1207_5P, MIR4524A_3P, MIR4703_5P, MIR6778_3P, MIR142_3P, MIR4766_3P, MIR4691_3P, MIR4693_5P
GO Biological Process (1): regulation of transcription by RNA polymerase II (GO:0006357)
GO Molecular Function (4): RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), sequence-specific double-stranded DNA binding (GO:1990837), DNA binding (GO:0003677)
GO Cellular Component (3): chromatin (GO:0000785), nucleus (GO:0005634), nucleoplasm (GO:0005654)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Maternal to zygotic transition (MZT) | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| transcription cis-regulatory region binding | 1 |
| chromatin | 1 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| double-stranded DNA binding | 1 |
| sequence-specific DNA binding | 1 |
| nucleic acid binding | 1 |
| chromosome | 1 |
| intracellular membrane-bounded organelle | 1 |
| nuclear lumen | 1 |
Protein interactions and networks
STRING
380 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| DUXA | LEUTX | A8MZ59 | 721 |
| DUXA | TPRX1 | Q8N7U7 | 705 |
| DUXA | ARGFX | A6NJG6 | 693 |
| DUXA | ZSCAN4 | Q8NAM6 | 579 |
| DUXA | NANOGNB | Q7Z5D8 | 548 |
| DUXA | MBD3L3 | A6NE82 | 507 |
| DUXA | ADAT1 | Q9BUB4 | 482 |
| DUXA | PLAC9 | Q5JTB6 | 449 |
| DUXA | RHOXF2B | P0C7M4 | 448 |
| DUXA | ANHX | E9PGG2 | 433 |
| DUXA | PRAMEF5 | Q5TYX0 | 432 |
| DUXA | ANXA11 | P50995 | 416 |
| DUXA | TERF2IP | Q9NYB0 | 410 |
| DUXA | PRAMEF1 | O95521 | 398 |
| DUXA | DPRX | A6NFQ7 | 396 |
| DUXA | MBD3L2 | Q8NHZ7 | 396 |
IntAct
0 interactions, top by confidence:
BioGRID (11): SMARCA5 (Proximity Label-MS), TOP2A (Proximity Label-MS), SMARCA1 (Proximity Label-MS), MKI67 (Proximity Label-MS), BPTF (Proximity Label-MS), MDC1 (Proximity Label-MS), ZNF512B (Proximity Label-MS), ARID3A (Proximity Label-MS), BAZ1A (Proximity Label-MS), CHD7 (Proximity Label-MS), BAZ1B (Proximity Label-MS)
ESM2 similar proteins: A0A1W2PPF3, A1YGA2, A1YGI6, A2T777, A6NLW8, E9Q3T6, G5E8B9, O43167, O88436, O97670, P09075, P09076, P09532, P09634, P10178, P14150, P14839, P18863, P18866, P20269, P21523, P23459, P31261, P31538, P49925, P50209, P50210, P51783, P87393, Q05007, Q05095, Q28598, Q28601, Q28J15, Q3B725, Q3UL53, Q61658, Q6P2A1, Q804R0, Q80X44
Diamond homologs: A0A1W2PPF3, A1YEY5, A1YFI3, A1YG57, A2T733, A2T7P4, A6NLW8, A6NNA5, F1NEA7, G5EBU4, G5EDS1, O18381, O35137, O35160, O42250, O43186, O43316, O43812, O54751, O70137, O73917, O75360, O75364, O95076, P09088, P0CJ85, P0CJ86, P0CJ87, P0CJ88, P0CJ89, P0CJ90, P21711, P22810, P26367, P26630, P29454, P32242, P32243, P34764, P34765
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
32 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 28 |
| Likely benign | 3 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
666 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:57154480:CAC:C | acceptor_gain | 1.0000 |
| 19:57154483:C:CC | acceptor_gain | 1.0000 |
| 19:57155368:CAAAT:C | acceptor_gain | 1.0000 |
| 19:57155373:C:CC | acceptor_gain | 1.0000 |
| 19:57158325:CACTT:C | donor_loss | 1.0000 |
| 19:57158326:A:AC | donor_gain | 1.0000 |
| 19:57158326:ACT:A | donor_loss | 1.0000 |
| 19:57158327:C:CT | donor_gain | 1.0000 |
| 19:57158470:CTAC:C | acceptor_gain | 1.0000 |
| 19:57158474:C:CC | acceptor_gain | 1.0000 |
| 19:57158474:CT:C | acceptor_loss | 1.0000 |
| 19:57159165:A:AC | donor_gain | 1.0000 |
| 19:57159166:C:CC | donor_gain | 1.0000 |
| 19:57159168:TTGAA:T | donor_gain | 1.0000 |
| 19:57160638:CTTA:C | donor_loss | 1.0000 |
| 19:57160639:TTAC:T | donor_loss | 1.0000 |
| 19:57160640:TACCT:T | donor_loss | 1.0000 |
| 19:57160641:A:T | donor_loss | 1.0000 |
| 19:57160642:C:CT | donor_loss | 1.0000 |
| 19:57160793:CATCT:C | acceptor_gain | 1.0000 |
| 19:57160794:ATCT:A | acceptor_gain | 1.0000 |
| 19:57160796:CT:C | acceptor_gain | 1.0000 |
| 19:57160797:TC:T | acceptor_loss | 1.0000 |
| 19:57160798:C:CC | acceptor_gain | 1.0000 |
| 19:57160798:C:CG | acceptor_loss | 1.0000 |
| 19:57160799:T:A | acceptor_loss | 1.0000 |
| 19:57160809:T:TC | acceptor_gain | 1.0000 |
| 19:57155372:TC:T | acceptor_loss | 0.9900 |
| 19:57155373:CT:C | acceptor_loss | 0.9900 |
| 19:57155374:T:G | acceptor_loss | 0.9900 |
AlphaMissense
1341 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:57155364:G:C | F149L | 0.998 |
| 19:57155364:G:T | F149L | 0.998 |
| 19:57155366:A:G | F149L | 0.998 |
| 19:57158406:A:C | F120L | 0.997 |
| 19:57158406:A:T | F120L | 0.997 |
| 19:57158408:A:G | F120L | 0.997 |
| 19:57159270:A:C | F63L | 0.997 |
| 19:57159270:A:T | F63L | 0.997 |
| 19:57159272:A:G | F63L | 0.997 |
| 19:57155352:T:A | R153S | 0.995 |
| 19:57155352:T:G | R153S | 0.995 |
| 19:57155365:A:G | F149S | 0.995 |
| 19:57158332:A:T | V145D | 0.995 |
| 19:57159258:T:A | R67S | 0.995 |
| 19:57159258:T:G | R67S | 0.995 |
| 19:57155369:A:G | W148R | 0.994 |
| 19:57155369:A:T | W148R | 0.994 |
| 19:57158373:T:A | R131S | 0.994 |
| 19:57158373:T:G | R131S | 0.994 |
| 19:57159271:A:G | F63S | 0.994 |
| 19:57159275:A:G | W62R | 0.994 |
| 19:57159275:A:T | W62R | 0.994 |
| 19:57160721:G:C | F34L | 0.994 |
| 19:57160721:G:T | F34L | 0.994 |
| 19:57160723:A:G | F34L | 0.994 |
| 19:57155353:C:G | R153T | 0.993 |
| 19:57158362:G:T | A135D | 0.993 |
| 19:57158419:A:G | L116P | 0.991 |
| 19:57158363:C:G | A135P | 0.990 |
| 19:57155356:C:G | R152P | 0.989 |
dbSNP variants (sampled 300 via entrez): RS1000149076 (19:57153750 C>T), RS1000158882 (19:57153978 G>A), RS1000284050 (19:57169203 C>T), RS1000300830 (19:57159789 A>T), RS1000491347 (19:57163733 T>G), RS1000580912 (19:57168995 C>G,T), RS1000790728 (19:57158610 G>T), RS1000982260 (19:57156141 G>T), RS1000992140 (19:57155789 C>T), RS1001285319 (19:57166291 A>G,T), RS1001311034 (19:57159750 C>A,T), RS1001631644 (19:57163465 A>G), RS1001787486 (19:57168453 T>C), RS1002059636 (19:57157257 A>C,T), RS1002709906 (19:57164612 G>C,T)
Disease associations
OMIM: gene MIM:611168 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001144_10 | Dupuytren’s disease | 7.000000e-14 |
| GCST004858_25 | Dupuytren’s disease | 2.000000e-17 |
| GCST010396_251 | Gut microbiota (bacterial taxa, hurdle binary method) | 2.000000e-07 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004229 | Dupuytren Contracture |
| EFO:0007874 | gut microbiome measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
8 total (human), top 8 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | decreases methylation | 1 |
| ferrous chloride | decreases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Arsenic | affects methylation | 1 |
| Cisplatin | increases expression | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Okadaic Acid | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.